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Abstract
Aim: The glutathione-dependent AdhC-EstD formaldehyde detoxification system is found in eukaryotes and
prokaryotes. It is established that it confers protection against formaldehyde that is produced from environ-
mental sources or methanol metabolism. Thus, its presence in the human host-adapted bacterial pathogen
Neisseria meningitidis is intriguing. This work defined the biological function of this system in the meningococcus
using phenotypic analyses of mutants linked to biochemical and structural characterization of purified enzymes.
Results: We demonstrated that mutants in the adhC and/or estD were sensitive to killing by formaldehyde.
Inactivation of adhC and/or estD also led to a loss of viability in biofilm communities, even in the absence of
exogenous formaldehyde. Detailed biochemical and structural analyses of the esterase component demonstrated
that S-formylglutathione was the only biologically relevant substrate for EstD. We further showed that an
absolutely conserved cysteine residue was covalently modified by S-glutathionylation. This leads to inactivation
of EstD. Innovation: The results provide several conceptual innovations. They provide a new insight into
formaldehyde detoxification in bacteria that do not generate formaldehyde during the catabolism of methanol.
Our results also indicate that the conserved cysteine, found in all EstD enzymes from humans to microbes, is a
site of enzyme regulation, probably via S-glutathionylation. Conclusion: The adhc-estD system protects against
formaldehyde produced during endogenous metabolism. Antioxid. Redox Signal. 18, 743–755.
Introduction
The highly cytotoxic compound formaldehyde is a by-product of numerous environmental processes (16). This
strong electrophile undergoes indiscriminate, nonenzymatic,
and rapid reactions with biological macromolecules, leading to
irreversible alkylations and cross-linkages, with resulting
damage to proteins and DNA (7). Thus, it comes as no surprise
that formaldehyde detoxification systems are diverse and
widespread across the biological world. These systems often
depend on the glutathione (GSH) pool, as it reacts spontane-
ouslywith formaldehyde to form S-hydroxymethylglutathione
(HMGSH, Fig. 1) (7). This adduct is in turn oxidized by a class
Innovation
The adhc-estD detoxification system for formaldehyde is
commonly understood to remove formaldehyde generated
from exogenous sources or as a by-product of methanol
metabolism. Our results suggest that the adhc-estD system
is required for protection against formaldehyde that is
generated during endogenousmetabolism. They provide a
new insight into formaldehyde detoxification in bacteria
that do not generate formaldehyde during the catabolism
of methanol.
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III, zinc-containing, NAD+ -dependent alcohol dehydrogenase
(AdhC) to generate S-formylglutathione (SFG) (48). GSH is
regenerated via subsequent hydrolysis of SFG by a thioesterase,
which also generates formate as a by-product (Fig. 1) (49).
It has been known for decades that formaldehyde is also
produced endogenously during cellular metabolism of etha-
nol and methanol. As a result, there is a wealth of literature
on this GSH-dependent detoxification system from the
mammalian liver and plants (12, 48). More recently, it was
recognized that Gram-negative methylotrophic bacteria also
employ a class-III alcohol dehydrogenase (AdhC) and a
thioesterase (EstD) to detoxify formaldehyde during metha-
nol metabolism (5, 6, 14, 50). Intriguingly, analysis of bacterial
genomes has revealed that adhC and estD genes are well dis-
tributed in bacteria that do not oxidize methanol. An example
is Escherichia coli, where formaldehyde induces the expression
of the operon consisting of frmR, encoding a formaldehyde-
responsive repressor, frmA (adhC), and frmB (estD) (13).
The bacterial pathogen Neisseria meningitidis is the etio-
logical agent of meningococcal meningitis. It is closely related
to Neisseria gonorrhoeae, the causative agent of gonorrhoea. In
both organisms, adhC and estD are found as an operon that is
controlled by NmlR, a MerR-like regulator that was recently
characterized in the gonococcus (24). While adhC is not func-
tional in all strains of N. gonorrhoeae due to a frameshift mu-
tation in the gene, the adhC gene in N. meningitidis has
remained intact (36). Like E. coli, these pathogenic Neisseria
species are not able to use methanol as a carbon source, and
thus the presence and function of these formaldehyde de-
toxification genes in their genome remain unclear. In this
study, we report the effect of mutation of adhC and estD on the
ability of N. meningitidis to defend against reactive aldehyde
stress. To understand the molecular basis of formaldehyde
defense in N. meningitidis, we carried out a biochemical
characterization of the esterase encoded by the adhC-estD
operon. We also report the crystal structure of EstD and de-
scribe its role in formaldehyde detoxification. Our studies
provide new insights into the covalent modification of a
conserved cysteine present at the enzyme active site of EstD.
Our results also provide an understanding of the possible
biological role of adhC and estD in defense against endoge-
nously produced formaldehyde.
Results
NMB1304 (adhC) and NMB1305 (estD)
are required for resistance to formaldehyde
in N. meningitidis
The operon consisting of NMB1304 and NMB1305 within
the N. meningitidis MC58 genome (44) contains genes that
were annotated as a adhC and an S-formylglutathione hy-
drolase (SFGH, EstD), respectively (Supplementary Fig. S1;
Supplementary Data are available online at www.liebertpub
.com/ars). This operon is also present in the meningococcal
C311#3 strain. We have sequenced these genes in both strains
and found them to be identical (data not shown). To assess the
functional role of this operon in the meningococcus, we con-
structed mutant strains in which the entire bicistron or each
of the individual genes was replaced with a kanamycin-resis-
tance cassette (Supplementary Fig. S1), creating C311#3adhC,
C311#3estD, and C311#3adhC-estD. These engineered strains
were subsequently challenged with a range of reactive alde-
hydes: formaldehyde aswell as glutaraldehyde, glycolaldehyde,
glyoxal, and methylglyoxal. Figure 2A shows the results from a
disc-diffusion killing assay, where the wild-type and mutant
strains displayed similar zones of growth inhibition for all che-
mical challenges, with the exception of formaldehyde. In this
case, a significant increase in the zone of inhibitionwas observed
for the single and double NMB1304 and NMB1305 mutant
strains when compared to wild-type meningococci. Additional
short-chain aldehydes, such as acetaldehyde and propionalde-
hyde, were also tested, but no difference between the mutant
strains was observed (Supplementary Fig. S2).
To confirm this formaldehyde-sensitive phenotype, we
developed a killing assay where serial dilutions of meningo-
cocci were plated on a solid medium containing increasing
concentrations of formaldehyde (0–1.6mM). Figure 2B con-
firmed that mutants of the NMB1304-1305 operon were more
sensitive to killing by formaldehyde than wild-type cells. The
data also indicated that this sensitivity was most pronounced
for the NMB1305 single mutant. This observation was con-
firmed when the colony counts of cells grown in the presence
of formaldehyde were determined. Figure 2C shows the re-
covery of colony-forming units (CFUs) after incubation with
decreasing concentrations of formaldehyde for the wild-type
cells. Compared to the wild type, there was a decline in CFU
recovery as a function of formaldehyde concentration for the
NMB1304 single and NMB1304-1305 double mutants that
followed an almost identical pattern. However, the CFU re-
covery for the NMB1305 single mutant was notably lower
than for the other two mutants, and this loss of CFU also
began at lower formaldehyde concentrations (Fig. 2C).
Complementation of eachmutant by insertion of a single copy
of the entire NMB1304-1305 operon into the meningococcal
chromosome led to a complete recovery of the wild-type
formaldehyde-resistant phenotype (Fig. 2D). Taken together,
these results confirmed the annotation of NMB1304 and
NMB1305 as adhC and estD, respectively, and confirmed the
role of these gene products in the protection against formal-
dehyde toxicity in N. meningitidis.
adhC and estD are required for survival in biofilms
N. meningitidis is an obligate human pathogen that fre-
quently colonizes the nasopharynx, and formation of menin-
gococcal biofilms on the nasopharyngeal epithelial cells is a
key virulence factor (33). We examined biofilm formation by
wild-type meningococci and adhC, estD, and adhC-estD mu-
tant strains on glass coverslips over a period of 24 h. No ex-
ogenous formaldehyde was added in these experiments.
COMSTAT analyses found no significant difference in the
abilities of these strains to form biofilms, as indicated by
biofilm thickness and average biomass (Fig. 3A). However,
when we evaluated the survival of meningococci within the
biofilm matrix using a viability stain, we observed that while
wild-type cells survived, and the adhC, estD, and adhC-estD
mutant strains were nonviable (Fig. 3B and Supplementary
FIG. 1. Proposed reaction mechanism of formaldehyde
detoxification by AdhC and EstD.
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Fig. S3). This apparent aging of biofilms points to a possible
role of the adhC-estD operon in the survival of N. meningitidis.
NmEstD is an SFGH
The gene product of estD (herein referred to as NmEstD)
exhibits high sequence identity (40%–60%) with several
SFGHs from human (ESD), Saccharomyces cerevisiae (YJG8),
and E. coli (FrmB and YeiG). In particular, the serine catalytic
triad (Ser145-Asp221-His254) in NmEstD is fully conserved
(Supplementary Fig. S4). To confirm the expectation that
NmEstD functions as a typical SFGH, it was expressed as a
recombinant protein in E. coli with a hexa-His epitope at the
N-terminus. The enzyme was obtained routinely in high yield
(*300mg/L culture) and purity ( > 95% pure) in a dimeric
and fully reduced form (Supplementary Fig. S5 and Supple-
mentary Table S1, respectively). The purified enzyme was
subsequently assayed for activity against SFG. We also tested
S-lactoylglutathione (SLG), a naturally occurring thioester
that is produced during the removal of methylglyoxal using
the glyoxalase system. The synthetic carboxyl ester p-
nitrophenyl acetate (pNPAC) was used as a positive control
for the reaction. NmEstD was active toward all tested sub-
strates, and Table 1 lists the kinetic parameters obtained for
the NmEstD-catalyzed hydrolysis of these substrates under
the same conditions. The catalytic efficiencies toward pNPAC
(kcat/Km 3.2·103M-1 s-1) and SLG (kcat/Km 2.90·103M-1 s-1)
were comparable to those reported previously for other SFGHs
(Table 2). However, the highest activity of NmEstD was ob-
tained with SFG (kcat/Km 1.95· 106 M-1 s-1) (Fig. 4), with a
catalytic efficiency of at least three orders of magnitude higher
than those obtained for pNPAC and SLG. Itwas also noted that
the specificity rate constant toward SFG was at least 25-fold
higher than those reported previously for other SFGHs (Table
2). These results are consistent with the conclusion that SFG is
the likely physiological substrate of NmEstD.
FIG. 2. The adhC-estD operon in Neisseria meningitidis confers resistance to formaldehyde. (A) Sensitivity of menin-
gococci to reactive aldehydes, as determined by disc diffusion assay. Black bars, wild type; white bars, adhC mutant; dark
gray bars, estD mutant; light gray bars, adhC-estD mutant. MG, methylglyoxal; GTA, glutaraldehyde; GCA, glycoaldehyde;
FA, formaldehyde. Six independent experiments were performed. Y-error bars indicate – standard error from the mean.
*p < 0.0002; **p< 0.0005; ***p< 0.0007. (B) Growth of meningococci on a solid medium containing increasing concentrations of
formaldehyde as indicated. The experiment was repeated at least three times, and representative results are shown. Number
of cells inoculated is shown on the Y-axis. (C) Bacterial count after overnight growth on a formaldehyde-containing medium
as in panel B. Filled circles (C), wild type; empty circles (B), adhC mutant; filled triangles (;), estD mutant; empty triangles
(6), adhC-estD mutant. Three independent experiments were performed. Y-error bars indicate– standard error from the
mean. (D) Recovery of resistance to formaldehyde by chromosomal complementation with an intact adhC-estD operon. Filled
circles (C), wild type; empty circles (B), estD mutant; filled triangles (;), estD adhC-estD + complemented mutant; empty
triangles (6) adhC-estD mutant; filled squares (-), adhC-estD adhC-estD + complemented mutant.
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Despite the presence of a serine catalytic triad, the absolute
conservation of a cysteine residue (Cys54 in NmEstD; Sup-
plementary Fig. S4) among various SFGH homologs and the
sensitivity of these enzymes to thiol-modifying reagents led to
their initial misclassification as cysteine hydrolases (28). In
this study, we confirmed that NmEstD functions using a
typical serine hydrolase active site. Substitution of the active-
site serine (Ser145 in NmEstD) with alanine completely
abolished enzyme activity toward all tested substrates (Table
1). We also tested the effect of replacing Cys54with alanine on
enzyme activity. TheC54Amutant hadKm values comparable
to those of the wild-type enzyme toward all tested substrates
(Table 1). However, we noted that this mutant exhibited a
small (19%) decrease in its kcat value toward SFG compared to
wild-type NmEstD. Similarly, alanine substitution of a sec-
ond, solvent-exposed cysteine (Cys26) did not affect enzyme
activity toward SLG or pNPAC, and only a minimal decrease
in kcat (1.7-fold) was detected for SFG (Table 1). These results
confirmed that Cys54 is not involved in a direct catalytic role.
Structural characterization of NmEstD
To characterize the molecular basis of the apparent speci-
ficity for SFG,we determined the crystal structure of NmEstD.
Crystals of NmEstD had the symmetry of the hexagonal space
group (P6522), two molecules per asymmetric unit, and they
diffracted to 1.3 A˚ resolution. Statistics for data processing
and structure refinement are listed in Table 3. The NmEstD
structure reveals a typical a/b hydrolase fold displayed by
other members of the SFGH family (35). Nine central mixed b-
strands (b1–b9) form a twisted b-sheet that is surrounded by
nine a-helices [aA-aI; secondary structure notation as in (35)]
and three 310 helices (Fig. 5A). There is one large dimer in-
terface in the NmEstD crystals (occluding*900 A˚2 of solvent
accessible area per monomer), and it involves polar and
nonpolar interactions (Fig. 5D) between residues in b1–b2,
aA–aB, and aI. Electrostatic interactions involve the side
chains of Asp253 and His7 in one monomer and the hydroxyl
group of Tyr252 and the main-chain N-atom of Gly11 in the
other monomer. Further contacts involve cation-p interaction
between Arg67 in one monomer and Phe10 and Tyr68 in the
other (Fig. 5C). These residues are conserved among other
bacterial SFGHs, but have been substituted in eukaryotic
proteins (Supplementary Fig. S4).
The structure further revealed that the substrate-binding
pocket of NmEstD displayed an overall positive charge due to
residues Asn58, Lys62, and His144 (Fig. 5C). These residues
are conserved among NmEstD homologs and may be im-
portant for orienting the GSH moiety within the active site.
Indeed, the dimensions of this site (roughly 14· 8· 6 A˚) can
easily accommodate the GSH moiety in both SFG and SLG
substrates. However, despite various attempts, we were un-
able to cocrystallize NmEstD with its substrates. Thus, we
employed a simple docking protocol to model binding of SFG
in this substrate pocket. These in silico analyses confirmed that
atoms from residues Asn58 and Lys62 are well positioned to
form hydrogen bonds to charged groups from the GSH moi-
ety (Fig. 6A, B). These residues are likely to be important for
the proper orientation of the substrate into the active site.
However, the size of the side chain attached to GSH is central
in defining substrate specificity. Previous studies have shown
that the size of the substrate that can be accommodated in the
active site is defined by the acyl pocket (9, 10, 29). The acyl
pocket of NmEstD is highly similar to those previously seen
for other SFGHs and is formed by residues Leu52, Tyr94,
Ile171, Trp179, Phe223, and Leu228 (Fig. 5B). It is likely that
this shallow acyl pocket of NmEstD is responsible for its
FIG. 3. The adhC-estD operon is required for biofilm vi-
ability. (A) COMSTAT analysis of biofilmbiomass (black bars)
and average thickness (white bars). The error bars repre-
sent– standard error of the mean. No statistical difference
( p£ 0.05) was observed in either the biomass or thickness of the
biofilms formed by the adhC, estD, and adhC-estD mutants
relative to the wild-type strain. These results are the combina-
tion of three independent experiments. (B) Three-dimensional
reconstructions of stacked z-series of meningococcal wild-type,
adhC, estD, and adhC-estD mutants grown over glass taken at
200·magnification and rendered using EZ-C1 viewer (Nikon).
Cells staining green represent viable cells, while cells staining
red represent dead cells. These experiments were performed
three times, and representative results are shown. (To see this
illustration in color, the reader is referred to the web version of
this article at www.liebertpub.com/ars.)
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preference for SFG over bulkier substrates such as SLG, or
those with aromatic moieties like pNPAC. The presence of an
orderedwatermolecule (B factor 12.4 A˚2) in close proximity to
the enzyme active site further allowed us to identify the
oxyanion hole in NmEstD. Based on the proposed reaction
mechanism for SFGHs (9, 29), the O atom from the formate
moiety in SFG interacts with backbone amide groups from the
oxyanion hole. In the NmEstD structure, the O atom from the
water molecule is within 3.1 A˚ of the backbone amide groups
of Leu52 and Met146, and therefore these residues are the
most likely candidates to for the oxyanion hole in NmEstD.
Cys54 is S-glutathionylated by reaction
with S-nitrosoglutathione
There is increasing evidence that cysteine residues can
function as redox switches and control the catalytic activity of
enzymes (26). Thiol-modifying compounds have been shown
previously to target the conserved cysteine residue in SFGH
homologs from S. cerevisiae, Arabidopsis thaliana, and E. coli,
which has led to the suggestion that this residue (Cys54 in
NmEstD) may play a role in the secondary regulation of en-
zyme activity (9, 13, 29). In this work, we tested the reactivity
of the cysteines inNmEstD toward synthetic alkylating agents
and analyzed the reaction products by electrospray ionization
mass spectrometry (ESI MS). Incubation with a large excess of
iodoacetamide (IA; 50 molar equivalents) led to a mass in-
crease of + 57Da compared to the untreated reduced protein
(Fig. 7A). These results are consistent with the alkylation of
only one of the two solvent-exposed Cys residues in NmEstD.
We extended this work to determine if NmEstD could
be covalently modified via S-glutathionylation. Incubation
with various molar ratios of the naturally occurring reagent
S-nitrosoglutathione (GSNO) increased the mass of NmEstD
by + 305Da, corresponding to the attachment of a single GSH
moiety to one Cys residue (Fig. 7B). A second biologically
relevant S-glutathionylation agent, oxidized glutathione
(GSSG), was also used in these experiments, but it did not
modify the enzyme with the same efficiency as GSNO (data
not shown). To identify the reactive cysteine in NmEstD, two
protein variants were produced in which each of the surface
Cys residues was replaced with an alanine. In the C26A var-
iant, only Cys54 is accessible to the solvent. Likewise, in the
C54A variant, only Cys26 is present at the surface. GSNO
treatment followed by ESI MS analyses revealed that the
C26A variant was modified almost to completion, while only
a third of the C54A mutant was modified under the same
conditions (Fig. 7B). In addition, the C54A mutant was also
resistant to S-alkylation by IA (Fig. 7A). Taken together, the
above results suggest that Cys54 is in fact the reactive Cys
residue in NmEstD.
We further examined the effect of Cys54 modification on
the thioesterase activity of NmEstD. For simplicity, we used
the C26A and C54A mutants of NmEstD in these studies, as
each mutant only contained one solvent-accessible Cys resi-
due. Figure 7C shows that activity of the C54A mutant
Table 1. Kinetic Parameters of NmEstD and Its Variants
Protein Substrate Km (mM) Vmax (mmol.min
- 1.mmol protein - 1) kcat (s
- 1) kcat/Km (M
- 1s- 1)
WT SFG 2.21 – 0.35 2.6 · 105 – 1.8 · 104 4300 1.95 · 106
SLG 2.69 – 0.47 4.8 · 102 – 0.3 · 102 7.90 2.90 · 103
pNPAC 0.62 – 0.06 1.2 · 102 – 0.3 · 102 2.00 3.20 · 103
C54A SFG 2.77 – 0.26 2.1 · 105 – 9.4 · 103 3500 1.26 · 106
SLG 2.08 – 0.52 1.6 · 102 – 0.1 · 102 2.70 1.30 · 103
pNPAC 0.79 – 0.06 7.8 · 101 – 2.7 · 101 1.30 1.65 · 103
C26A SFG 4.23 – 0.66 1.6 · 105 – 1.4 · 104 2600 6.15 · 105
SLG 3.00 – 0.90 5.2 · 102 – 0.6 · 102 8.70 2.90 · 103
pNPAC 0.48 – 0.05 9.5 · 101 – 2.9 · 101 1.60 3.30 · 103
S145A SFG ND ND ND ND
SLG ND ND ND ND
pNPAC ND ND ND ND
ND, not detectable; pNPAC, p-nitrophenyl acetate; SFG, S-formylglutathione; SLG, S-lactoylglutathione.
Table 2. Kinetic Parameters of EstD Homologs
SFG SLG pNPAC
Organism
Km
(mM)
kcat
(s - 1)
kcat/Km
(M - 1s - 1)
Km
(mM)
kcat
(s- 1)
kcat/Km
(M - 1s - 1)
Km
(mM)
kcat
(s - 1)
kcat/Km
(M - 1s- 1) Ref
Neisseria meningitidis 2.21 4300 2.0 · 106 2.69 7.9 2900 0.62 2 3200 This study
Saccharomyces cerevisiae ND ND ND > 1.25 ND ND 0.4 1.8a 4500a (29)
Escherichia coli FrmB 0.41 28.5 6.9 · 104 0.6 0.5 800 0.29 0.3 1030 (13)
E. coli YeiG 0.43 6.51 1.5 · 104b 0.58 1.02 1750 0.45 0.26 570 (13)
Arabidopsis thaliana 0.13 10.4c 4.6 · 104c ND ND ND 1.02 2.9c 2900c (27)
Agrobacterium tumefaciens ND ND ND ND ND ND 0.48 1.95 4070 (51)
aConverted from min- 1.
bCorrected value obtained from the data published.
cConverted from mM.s- 1 and kcat value as published.
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remained relatively unaffected by GSNO. In contrast, the
C26A mutant was inhibited under the same conditions. The
loss of activity was proportional to the amount of GSNO
added, and the activity was recovered by incubation with
dithiothreitol (DTT) (Fig. 7C). These results supported the
proposal that S-glutathionylation of Cys54 in NmEstD could
modulate the activity of this enzyme. However, this covalent
modification of Cys54 appeared to have no effect on its sec-
ondary structure (Supplementary Fig. S6) or dimeric state
(Supplementary Fig. S5). To this end, we have not been able to
crystallize the GSNO-modified form of NmEstD. Never-
theless, examination of the crystal structure showed that Cys54
is located in a loop between b4 and aA and sits at the entrance
to the catalytic site ofNmEstD (Fig. 5C).Wewere able tomodel
the impact of S-glutathionylation using a docking protocol as
described in the Materials and Methods section. These in silico
results suggest that thismodificationwould in fact block access
to the substrate-binding pocket of NmEstD, thus providing a
rationale behind the inhibition observed above (Fig. 6C).
To further characterize the role of Cys54 in the NmEstD-
mediated formaldehyde detoxification in vivo, we constructed a
C54AestD mutant strain by complementing the estD deletion
strain with a single copy of the same operon expressing a C54A
mutant ofNmEstD.Our killing assay showed that theC54AestD
mutant was resistant to formaldehyde to the level seen in wild-
type meningococci (Fig. 8). The same was observed when a
C26A mutation was introduced. By contrast, the S145AestD
mutant was sensitive to killing by formaldehyde, consistent
with our observation that the same mutation in the NmEstD
enzyme led to a complete loss of SFGH activity (cf. Table 1).
Discussion
The combination of an alcohol dehydrogenase and a serine
thioesterase represents an established system for the GSH-
dependent detoxification of formaldehyde across the biolog-
ical world. Although the first bacterial systems to be described
were those in gram-negative methylotrophs (5, 6, 14, 50), it
has become clear that adhC and estD are present in a wide
variety of bacteria, the majority of which do not generate
formaldehyde via methanol oxidation. N. meningitidis is one
such bacterium, and our in vitro killing assays demonstrate
that the primary function of the meningococcal adhC-estD
system is in fact to protect this bacterium against the toxic
effects of formaldehyde. This observation is similar to those
made for E. coli (13), a bacterium that can survive in a variety
of environments where it might be expected to encounter
formaldehyde. By contrast, N. meningitidis is an obligate hu-
man host-adapted bacterium, and this raises the question
about the circumstances under which this bacterium would
encounter this toxic aldehyde.
It is known that formaldehyde is produced endogenously
in host tissues from methylamine (8, 55). In addition, it also
appears to be formed during lipid peroxidation and hydroxyl
radical formation (40, 45), two processes that occur during
inflammation (32). Inflammation of the meninges of the brain
or spinal cord (meningitis) is associated with meningococcal
infection, and so it may be the case that the adhC-estD system
has a protective role during the systemic dissemination of
N. meningitidis. It is notable that a highly similar NmlR-
regulated adhC-estD system is found inHaemophilus influenzae,
a bacterium that can also spread systemically and also causes
FIG. 4. NmEstD is a SFGH. Activity of NmEstD was as-
sayed against SFG (filled circles,C), SLG (empty circles,B),
and pNPAC (filled triangles,;). The results were plotted as
a function of substrate concentration and fitted to a rectan-
gular hyperbola. All assays were performed in HEPES buffer
(50mM, pH 7.0) at 37C using 0.4 lM EstD for SLG and
pNPAC or 4 nM EstD for SFG. Units =lmol.min - 1. pNPAC,
p-nitrophenyl acetate; SFGH, S-formylglutathione hydrolase;
SLG, S-lactoylglutathione.
Table 3. Data Collection and Refinement
Statistics for NmEstD
Data collection and processing
X-ray source MX-2 Australian
Synchrotron
Wavelength (A˚) 0.954
Space group P6122
Cell dimensions [a, b, c (A˚)] 111.3, 111.3, 169.9
Resolution range (A˚)a 19.84–1.30 (1.30–1.37)
Rmerge (%)a 6.7 (80.8)
< I/rI > a 10.0 (1.0)
Completeness (%)a 99.3 (97.0)
Multiplicitya 5.2 (5.0)
Number of total reflectionsa 783,482 (106,886)
Number of unique reflectionsa 150,461 (21,149)
Refinement
Space group P6522
Resolution range (A˚2)a 19.84–1.40 (1.42–1.40)
Rwork/Rfree (%)
b 14.34/15.39
Average B-factor protein/
solvent (A˚2)
20.16/31.46
r.m.s. deviation bonds (lengths/
angles)
0.011 A˚/1.22
Ramachandran (%) favored/allowed 96.8/100.0
aNumbers in parentheses refer to the statistics for the highest
resolution shell.
bR =Shkl(jjFobshklj-jFcalchkljj)/jFobshklj, where jFobshklj and
jFcalchklj represent the observed and calculated structure factor
amplitudes, respectively.
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FIG. 5. X-ray crystal struc-
ture of NmEstD. (A) Cartoon
representation of the NmEstD
dimer. Active site residues and
those involved in the dimer
interface are shown as ball-
and-stick models. (B) Organi-
zation of the active site. Zoom-
in shows residues making up
the catalytic triad (S145, H254,
and D221) and acyl pocket as
highlighted in panel A. Hy-
drogen bonds between resi-
dues in the catalytic triad are
shown as dashed lines. (C)
Surface representation of the
active site as colored by elec-
trostatic potential (negative
[red], to positive [blue]). Re-
sidues contributing to the
overall positive charge are
shown as ball-and-stick mod-
els together with those in the
catalytic triad. Primed num-
bers indicate residues from the
second monomer. (D) Details
of the dimer interface. The
protein backbone is shown as a
ribbon, and residues taking
part in cation-p interactions are
shown as ball-and-stick mod-
els. Individual NmEstD
monomers are shown in dif-
ferent colors (green and blue).
Primed numbers indicate resi-
dues from the second mono-
mer. (To see this illustration
in color, the reader is referred
to the web version of this
article at www.liebertpub
.com/ars.)
FIG. 6. In silico models of NmEstD with its SFG substrate and S-glutathionylated Cys54. (A) Surface as colored by
electrostatic potential (negative [red], to positive [blue]) showing a cross-section of the substrate-binding pocket with the
docked substrate SFG. Residues making up the oxyanion hole are shown as ball-and-stick representation. Atoms from the
substrate are also shown as ball-and-stick representation. Potential hydrogen bonds are indicated by dashed lines. (B) Top
view of the substrate-binding pocket (as shown in A) with docked SFG. Potential hydrogen bonds between substrate and
enzyme atoms as suggested by the docking analysis are shown as dashed lines. (C)Modification of Cys54 by GSH blocks the
substrate-binding pocket as suggested by the docking analysis. GSH is shown as a stick model; SFG is also shown in the
background as a semitransparent ball-and-stick model. Docking of GSH was restrained by enforcing a disulfide bond
between the thiol groups from Cys54 and GSH (dark-yellow dashed line). GSH, glutathione. (To see this illustration in color,
the reader is referred to the web version of this article at www.liebertpub.com/ars.)
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inflammation and meningitis (23). A number of reactive al-
dehydes are produced as part of the innate immune response
to infection. Methylglyoxal and glycoaldehyde are produced
by neutrophils as a consequence of themyeloperoxidase-driven
oxidation of threonine and serine, respectively (4). However, as
observed forE. coli, mutation of estD (and adhC) did not alter the
susceptibility of N. meningitidis to methylglyoxal. Furthermore,
in the case of the meningococcal mutant, we observed no
change in sensitivity to these other reactive aldehydes. This
observation may also be explained by the low specificity dis-
played by NmEstD toward SLG, a product of methylglyoxal
detoxification. It is likely that the GloA/GloB system that is
widespread among bacteria (46), including N. meningitidis, is
responsible for defense against methylglyoxal toxicity.
Another possibility is that formaldehyde is generated en-
dogenously withinN. meningitidis during carbonmetabolism.
In H. influenzae, it is known that AdhC is most highly ex-
pressed under highly aerobic conditions (11), and we have
previously observed that an adhC mutant of this bacterium
grows more slowly under conditions of high oxygen tension
than wild-type cells (23). Under these conditions, interme-
diary carbon metabolism may generate higher internal levels
of sugar phosphates as a consequence of a switch to the
pentose phosphate cycle. The short-chain sugars of the pen-
tose phosphate cycle (erythrose and glyceraldehyde) have
the potential to form toxic dicarbonyl compounds (34), which
can drive formation of aldehydes from a-amino acids via a
process known as Strecker degradation (53). In the case of
glycine, the product formed would be formaldehyde. If this is
the case, then the adhC-estD system may be considered a de-
toxification system that is linked more closely to intermediary
metabolism rather than a defense system associated with pro-
tection against formaldehyde generated from exogenous sour-
ces. That the former might be true comes from our observation
that the viability of N. meningitidis cells within biofilm com-
munities was reduced in the adhC and estD mutants compared
FIG. 7. S-Glutathionylation of Cys54 by GSNO. (A)Mass spectra of NmEstD wild-type and C54A variant before and after
treatment with 50 equivalents of IA. (B)Mass spectra of NmEstD wild-type, C26A, and C54A variants after treatment with 0 or
15 molar equivalents of GSNO. S-glutathionylated forms (-SSG) are indicated on top of each spectrum. The mass spectrum of the
C26A mutant after additional treatment with DTT is shown. The peak indicated by an asterisk (+178Da) represents a modified
form of NmEstD due to the spontaneous alpha-N-6-phosphogluconoylation of the hexa-His epitope. (C) Effect of GSNO treatment
on the SFGH activity of NmEstD. The C26A and C54A variants from panel (A) were assayed for activity using 1mM SFG as
substrate. Black bars, C26A mutant protein; white bars, C54A mutant protein. (D) Recovery of activity by DTT. Black bars, wild-
type protein; white bars, C26A mutant. DTT, dithiothreitol; GSNO, S-nitrosoglutathione; IA, iodoacetamide. The error bars
represent– standard error of the mean. These experiments were performed three times and representative results are shown.
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to wild-type cells. This reduced viability or premature aging of
biofilms may be a consequence of the accumulation of the toxic
metabolites due to the inactivation of the adhC-estD formalde-
hyde detoxification system. This would be consistent with en-
dogenous formaldehyde stress in this bacterium.
AlthoughEstD is recognized as a part of theGSH-dependent
formaldehyde detoxification system, most studies have
focused on AdhC, based perhaps on the assumption that this
enzyme would be the more critical component of the defense
system. However, our observation that the estD mutant was
more sensitive to formaldehyde than the adhC single mutant or
even the adhC-estD double mutant may suggest the following:
(i) SFG itself is toxic, and/or (ii) the failure to regenerate re-
duced GSH in the estDmutant leads to GSH depletion and cell
death as a consequence of loss of intracellular thiol-redox poise.
That the latter might be the case is supported by observations
that mutations in systems that fail to generate NADPH and
thereby were unable to maintain the GSH pool in a reduced
state lead to increased sensitivity to formaldehyde (19). Further
work is needed to test if this is the case in N. meningitidis.
The biochemistry of NmEstD described in this study
has revealed features that were previously unrecognized.
NmEstD displayed a dramatic preference (50-fold) for SFG
compared to other possible substrates, including SLG and
pNPAC, which is presumably dictated by its small catalytic
site. Yet, despite the high conservation of residues that make
up the active site, such a high specificity for SFG by a pro-
karyotic or eukaryotic thioesterase has not been previously
reported. It is tempting to suggest that this feature is a part of
an adaptation mechanism by N. meningitidis, which thrives
under only a limited range of environment when compared to
that of other less-fastidious bacteria such as E. coli. The same
may be true for other host-adapted pathogens that carry this
thioesterase, such as N. gonorrhoeae and H. influenzae.
Previous reports identifying the sensitivity of EstD toward
cysteine-modifying agents lead to the incorrect suggestion that
the conserved Cys54 in NmEstD and its homologs played an
important a role in catalysis (28, 49). This idea has been con-
tradicted by a substantial body of evidence that SFGHs are
serine hydrolases (3, 9, 13, 51, 54), and our observation that
mutation of Ser154 inactivates NmEstD is entirely consistent
with the present models for SFGH mechanism. Nevertheless,
the possibility that Cys54 might have a biological function is
intriguing. The previous observation that modification of
Cys54 with thiol-specific reagents resulted in enzyme inacti-
vation led to the suggestion that Cys54may act as a gatekeeper
(9). Such a model is consistent with the structure of the active
site and the position of Cys54. We have extended this line of
thinking anddemonstrated thatNmEstDwas inactivated via S-
glutathionylation by a naturally occurring reagent GSNO. This
covalent modification is becoming increasingly recognized to
play a key regulatory role in biology (25). Unfortunately, we
were not able to generate diffracting crystals of the GSH-
modified form of NmEstD. However, our modeling of the
NmEstD structure with a GSH-modified Cys54 indicates that
the active sitewould indeed be blocked by such amodification.
It is possible that this modulation of activity via S-
glutathionylation may be linked to complexmetabolic signaling
associated with GSNO. It has been suggested that the interplay
between the metabolism of GSH and its derivatives, including
GSNO and HMGSH, could have a role in regulation of NO sig-
naling via S-nitrosylation of proteins (41). In fact, in mammals,
yeast, and E. coli, AdhC is known to catalyze the NADH-de-
pendent reduction of GSNO (30), and it has been proposed that
this enzyme protects against nitrosative stress (17, 30, 42). Inter-
estingly, EstD is not generally considered to play a role in the
removal of the products of GSNO reduction (41). In the present
study, we found that compared to the wild-type strain, neither
the adhC nor the estD mutants of N. meningitidis were any more
sensitive to killing by generators of nitrosative stress such as ni-
trite and GSNO (Chen, Djoko, and McEwan, unpublished ob-
servations). In addition, purified NmEstD was unable to remove
the products of AdhC-catalyzed detoxification of GSNO (Chen,
Djoko, and McEwan, unpublished observations). Our observa-
tion thatNmEstD is highly specific for SFG supports the idea that
the AdhC-EstD system in the meningococcus is dedicated solely
to the removal of formaldehyde and not any other toxic species.
Our biofilm results further suggest that this pathway represents
an innate mechanism for survival in the human host.
Materials and Methods
Chemicals and reagents
Unless otherwise specified, chemicals were obtained from
commercial suppliers. GSNO (15) and SFG (47) were syn-
thesized as described previously.
Bacterial strains and culture conditions
Uncapsulated N. meningitidis strain C311#3 (52) was
propagated on a solid brain–heart infusion (BHI) medium
(Oxoid, Adelaide, South Australia) supplemented with 10%
(v/v) Levinthal’s base (2), and grown by incubation at 37 C
and 5% CO2. E. coli strains DH5a and BL21(DE3) were
FIG. 8. A C54AestD mutant, but not S145AestD, is resis-
tant to formaldehyde. Bacterial counts after overnight growth
on a solid medium containing formaldehyde (0–1.6mM).
Filled circles (C), wild type; empty circles (B), estD mutant;
filled triangles (;), estD adhC-estD C26A+ complemented
mutant; empty triangles (6), estD adhC-estD C54A+
complemented mutant; filled squares (-), estD adhC-estD
S145A+ complemented mutant.
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cultured on a Luria-Bertani (LB) medium.Where appropriate,
kanamycin (100 lg/ml), spectinomycin (50lg/ml), or ampi-
cillin (100 lg/ml) was used.
Construction of mutant meningococcal strains
Meningococcal adhC (NMB1304) gene, estD (NMB1305)
gene, and the adhC-estD operon were inactivated by deletion
and subsequent insertion of a kanamycin-resistance cassette as
illustrated in Supplementary Figure S1. Briefly, the upstream
and downstream flanking regions of the target gene (H1 and
H2, respectively) were amplified separately by polymerase
chain reaction (PCR) using primers listed in Supplementary
Table S2 and combined with the kanamycin cassette via splice-
overlap PCR. The resulting constructs were cloned into the
SmaI site of pUC19 to generate pUC19::adhC::kan, pU-
C19::estD::kan, and pUC19::adhC-estD::kan. Plasmids were
linearized with EcoRI and transformed into N. meningitidis
C311#3 wild-type strain. Kanamycin-resistant transformants
were selected, and correct insertion of the kanamycin cassette
was confirmed by PCR using primers that annealed to regions
flanking each insertion (Supplementary Table S2).
Mutant meningococci were complemented by inserting a
wild-type copy of the entire adhC-estD operon and a specti-
nomycin-resistance cassette into the proB gene in the N. me-
ningitidis chromosome (43). Briefly, a region containing the
adhC-estD operon was amplified by PCR using the primers
AEnm_comp_XmaI_F and AEnm_comp_AflII_R (Supple-
mentary Table S2), and the product was inserted between the
XmaI and AflII sites of pCTS32. The resulting plasmid
pCTS32::adhC-estD was linearized with NdeI before transfor-
mation. Positive transformants were checked with PCR using
the primer pair proBnm-F/R (Supplementary Table S2).
To generate site-directed variants of the estD gene, the estD
single-mutant strain was complemented as described above
with the C26AestD, C54AestD, or S145AestD gene. The desired
mutation was introduced by splice-overlap PCR using primers
as listed in Supplementary Table S2. All mutant strains con-
structed in this studywere confirmed throughDNA sequencing.
Bacterial sensitivity assays
Sensitivity of N. meningitidis C311#3 to reactive aldehydes
was tested usingmethylglyoxal (40%w/v), glyoxal (40%w/v),
glutaraldehyde (25% w/v), glycoaldehyde (1 M), and form-
aldehyde (35%–40%w/v). Disc diffusion susceptibility assays
were performed by placing paper discs containing 10 ll of
each stress reagent onto a lawn of meningococci on a BHI
medium. After overnight incubation, the zone of clearing
around the disc was measured. Sensitivity to formaldehyde
was also examined by a modified killing assay. Briefly, fresh
lawns of meningococci from an overnight agar plate were re-
suspended in phosphate-buffered saline (PBS) to an OD600 of
0.4 (*8· 107 CFU/ml). Serial dilutions (5ll each) were plated
on a BHI solidmedium containing increasing concentrations of
formaldehyde (0–1.6mM). Survival was assessed by counting
the number of visible colonies after overnight growth.
Growth of biofilms in continuous-flow chambers
over glass
N.meningitidisC311#3wild-type, adhC, estD, and adhC-estD
mutants were assayed for their abilities to form biofilms over
glass coverslips as described previously (39). The strains were
grown to an OD600 of 0.25 in a GC medium supplemented
with 1% IsoVitaleX (Becton Dickinson, North Ryde, NSW,
Australia), Kellogg’s supplements (22), and 0.042% w/v so-
dium bicarbonate. This cell suspension was used to inoculate
a continuous-flow chamber. Cells were allowed to adhere to
the glass surface for 1 h at 37C before the chambers were
incubated for 24 h under a flow rate of 180 ll biofilm medium
(a GC medium diluted 1:4 in PBS with 1% IsoVitaleX and
Kellogg’s supplements added) per minute. At the end of the
experiment, the effluent was cultured to check for contami-
nation, and the biofilm was stained using LIVE/DEAD Bac-
Light bacterial viability stain (Invitrogen, Mulgrave, VIC,
Australia). Z-series photomicrographs were scanned with a
Nikon C1 confocalmicroscope, and three-dimensional images
were rendered using EZ-C1 software (Nikon, Lidcombe,
NSW, Australia). COMSTAT analyses were performed on
each z-series to quantify the average biomass and thickness
(18).
Expression and purification of NmEstD
The estD gene was amplified from the chromosomal DNA
of N. meningitidis C311#3 using the cloning primer pair
estDnm_NdeI_F/R (Supplementary Table S2). Site-directed
Cys variants were constructed by splice-overlap PCR using
primers carrying the desired mutation (Supplementary Table
S2). The resulting PCR products were inserted between NdeI
and BamHI sites of plasmid pET-15b (Novagen, Kilsyth, VIC,
Australia) and transformed into E. coli strain BL21(DE3) for
protein overexpression. Bacteria were grown in an LB me-
dium (1L) containing ampicillin at 37C with vigorous
shaking at 200 rpm. When the OD600 reached 0.4, isopropyl 1-
thio-b-D-galactopyranoside (0.4mM) was added. Cells were
harvested after 5 h of further growth. Cell pellets were re-
suspended in 50ml of Buffer A (25mM Tris–HCl, 15mM
imidazole, 300mM NaCl, and 5mM b-mercaptoethanol, pH
8.0) and lysed by three passages through a French pressure
cell (16,000 psi) (Thermo Fisher, Scorseby, VIC, Australia).
NmEstD proteins were purified by metal ion affinity
chromatography using aHiTrap Chelating Sepharose column
(5ml; GE Healthcare, Rydalmere, NSW, Australia) in Buffer
A. Briefly, crude lysates were cleared by centrifugation and
loaded on the column. Unbound proteins were removed by
washingwith Buffer A, and bound proteins were eluted using
a linear gradient of 0–500mM imidazole in the same buffer.
Fractions containing NmEstD were pooled, and dialyzed into
the Tris–HCl buffer (20mM, 1mMDTT, pH 8.0). The purity of
each protein preparation was checked routinely by SDS-
PAGE. The identity of each protein was confirmed by ESI MS
as described below (Supplementary Table S3). Protein con-
centrations were quantified using solution absorbances at
280 nm (e280, 51,300 M
- 1cm - 1).
Generation of S-glutathionylated forms of NmEstD
Reduced forms of NmEstD (50lM) were prepared by in-
cubation with excess DTT (100 molar equivalents) for 30min,
followed by desalting into the HEPES buffer (50mM, pH 7.0).
To generate S-glutathionylated forms, GSNOwas added, and
the mixture was incubated for 1 h at 37C in the dark. Un-
reacted GSNO was removed by elution on a PD-10 (GE
Healthcare) column. Each modified form of NmEstD was
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identified using ESI MS. The esterase activity was also as-
sayed immediately using 2mM pNPAC and 1mM SFG as
described below.
Measurement of esterase activity
Carboxylesterase activities of wild-type Cys variants and S-
glutathionylated forms of NmEstD were assayed using
pNPAC as a substrate. Briefly, to a solution of pNPAC (0–
4mM) in the HEPES buffer (50mM, pH 7), NmEstD (0.4 lM)
was added, and generation of p-nitrophenol wasmonitored at
37C at 400 nm (e, 16,400M - 1 cm- 1). Initial rates of reactions
were calculated from the rate obtained 30 s after the addition
of NmEstD, and the results were plotted as a function of
substrate concentration. Michaelis–Menten parameters were
obtained by nonlinear regression to a rectangular hyperbola.
Thioesterase activity was measured as above, but using
SLG (0–10mM) or SFG (0–4mM) as substrates. Hydrolysis of
the thioester bond was monitored at 240 nm (e, 3100 and 3000
M - 1 cm - 1 for SLG and SFG, respectively) (47), except when
higher concentrations of SLG were used (5–10mM), in which
case the solution absorbance at 247 nmwasmonitored (e, 1675
M - 1cm - 1). Due to the high activity of EstD toward SFG, only
4 nM of NmEstD was used in these assays.
Electrospray ionization mass spectrometry
NmEstD samples (10–20 lM) were prepared in 50% ace-
tonitrile containing 0.01% formic acid. Spectral data were
collected on QSTAR Pulsar ESI-QqTOF (Applied Biosystems,
Mulgrave, VIC, Australia) using the positive ion (ESI + ) mode
with a cone voltage 25–35V and a flow rate of 5 ll acetonitrile
per min. The average molar mass of each sample was ob-
tained by applying a deconvolution algorithm to the recorded
spectrum, which was calibrated with horse heart myoglobin
(16,951Da).
Crystal structure determination and structural analysis
NmEstD was crystallized by hanging-drop vapor diffusion
in 25mM bis-Tris (pH 6.5), 200mM lithium sulfate, and 25%
PEG 3350. Crystallization drops consisted of 2ll of purified
EstD at 20mg/ml in 10mM HEPES, pH 7.0, 1mM DTT, and
2.0 ll reservoir solution. Large (0.3 · 0.1 · 0.1mm), hexagonal
crystals were grown at 293K. Before X-ray diffraction analy-
sis, crystals were mounted on nylon loops (Hampton Re-
search, Aliso Viejo, CA) and flash-cooled by plunging into a
liquid nitrogen bath. To preserve the diffraction quality of the
crystals after flash cooling, 1ll of a solution containing the
reservoir solution supplemented with 20% glycerol was ad-
ded directly to the crystallization drop. A complete diffraction
dataset from the EstD crystals was collected using a frame
width of 0.5  at the Australian Synchrotron (beamline MX2)
at 0.954 A˚ wavelength, using Blu-Ice software (31). Images
were processed using XDS (21), and scaled and merged using
software within the CCP4 suite (37). The crystallographic
phase problem was solved by molecular replacement using
the human EstD as the search model (PDB ID 3FCX). Mole-
cular replacement and structure refinement were performed
using the programs within PHENIX (1). Data processing and
structure refinement statistics can be found in Table 3. The
structure has been deposited in the Protein Data Bank (PDB
ID 4B6G).
In silico modeling of SFG binding to NmEstD
and S-glutathionylation of Cys54
Models for SFG andGSHwere generated using theDundee
PRODRUG server (38). All water molecules and ligands were
removed from the coordinate file of NmEstD before docking.
The program GOLD (20) was used for all docking calcula-
tions. All hydrogen atoms were added to the protein within
GOLD. For docking of SFG, the coordinates of the oxygen
atom from Ser145 defined a search radius of 15 A˚. Docking of
SFG to NmEstD was restrained based on ordered solvent
molecules foundwithin hydrogen bond distances of themain-
chain nitrogen atoms fromMet144 and Leu52 (oxyanion hole)
and the oxygen atom from Ser145. A similar protocol was
employed for the in silico modeling of S-glutathionylated
Cys54, but in this case, a disulfide bond was introduced be-
tween the sulfur atoms from the protein residue and that from
GSH. All other bonds in the GSH ligand were kept unre-
strained. For each ligand, 20 independent docking searches
were undertaken and scored with the default setting,
ChemPLP.
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Abbreviations Used
ADH¼ alcohol dehydrogenase
CFU¼ colony-forming unit
DTT¼dithiothreitol
ESI MS¼ electrospray ionization mass spectrometry
FA¼ formaldehyde
GCA¼ glycoaldehyde
GSH¼ glutathione
GSNO¼ S-nitrosoglutathione
GSSG¼ oxidized glutathione
GTA¼ glutaraldehyde
HMGSH¼ S-hydroxymethylglutathione
IA¼ iodoacetamide
LB¼Luria-Bertani
MG¼methylglyoxal
PBS¼phosphate-buffered saline
PCR¼polymerase chain reaction
pNPAC¼ p-nitrophenyl acetate
SFG¼ S-formylglutathione
SFGH¼ S-formylglutathione hydrolase
SLG¼ S-lactoylglutathione
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